An Open-Label, Multicohort, Phase II Study of Atezolizumab in Advanced Solid Tumors

Trial Profile

An Open-Label, Multicohort, Phase II Study of Atezolizumab in Advanced Solid Tumors

Recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Aug 2017

At a glance

  • Drugs Atezolizumab (Primary)
  • Indications Solid tumours
  • Focus Therapeutic Use
  • Acronyms Basket
  • Sponsors Roche
  • Most Recent Events

    • 19 Jul 2017 Planned End Date changed from 29 Nov 2020 to 12 Feb 2021.
    • 24 Apr 2017 Planned End Date changed from 1 Dec 2020 to 29 Nov 2020.
    • 24 Apr 2017 Planned primary completion date changed from 1 Dec 2020 to 29 Nov 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top